Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$80.37
$82.48
$39.40
$89.76
$3.58B1.55626,604 shsN/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$50.72
+0.7%
$53.06
$43.38
$62.88
$6.87B1.081.11 million shs144,278 shs
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$96.27
+1.8%
$102.07
$78.28
$212.43
$2.35B0.69249,762 shs14,243 shs
NuVasive, Inc. stock logo
NUVA
NuVasive
$39.75
$39.64
$35.17
$49.53
$2.08B1.071.16 million shsN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$35.10
-1.3%
$30.74
$13.82
$40.74
$2.27B1.121.71 million shs143,188 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cantel Medical Corp. stock logo
CMD
Cantel Medical
0.00%0.00%0.00%0.00%0.00%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-2.12%-0.77%-2.48%-6.31%-12.68%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-2.26%-2.45%-6.18%-1.13%-47.82%
NuVasive, Inc. stock logo
NUVA
NuVasive
0.00%0.00%0.00%0.00%-6.93%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+1.25%+14.97%+5.55%+55.22%-5.17%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cantel Medical Corp. stock logo
CMD
Cantel Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.8579 of 5 stars
3.32.00.04.12.74.23.1
ICU Medical, Inc. stock logo
ICUI
ICU Medical
4.3083 of 5 stars
3.51.00.03.92.52.51.9
NuVasive, Inc. stock logo
NUVA
NuVasive
N/AN/AN/AN/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
3.1803 of 5 stars
2.22.00.04.93.50.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cantel Medical Corp. stock logo
CMD
Cantel Medical
N/AN/AN/AN/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.67
Moderate Buy$66.3331.74% Upside
ICU Medical, Inc. stock logo
ICUI
ICU Medical
3.00
Buy$123.0030.12% Upside
NuVasive, Inc. stock logo
NUVA
NuVasive
2.50
Moderate Buy$51.3329.14% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.45
Hold$39.4510.95% Upside

Current Analyst Ratings

Latest CMD, TNDM, NUVA, ICUI, and GMED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
4/25/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$34.00 ➝ $45.00
4/23/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$37.00 ➝ $40.00
4/3/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$31.00 ➝ $38.00
3/26/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00 ➝ $37.00
3/18/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$60.00
3/15/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$25.00 ➝ $31.00
2/28/2024
ICU Medical, Inc. stock logo
ICUI
ICU Medical
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$134.00 ➝ $136.00
2/21/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$58.00 ➝ $60.00
2/21/2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$61.00 ➝ $64.00
2/6/2024
ICU Medical, Inc. stock logo
ICUI
ICU Medical
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$134.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$1.02B3.52$3.38 per share23.78$17.31 per share4.64
Globus Medical, Inc. stock logo
GMED
Globus Medical
$1.02B6.68$3.53 per share14.26$29.32 per share1.72
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$2.26B1.02$14.96 per share6.32$87.96 per share1.07
NuVasive, Inc. stock logo
NUVA
NuVasive
$1.23B1.70$4.96 per share8.01$17.02 per share2.34
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$747.72M3.07N/AN/A$4.81 per share7.39

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$13.71M$1.6569.2828.911.634.72%12.13%4.45%N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$1.1743.0315.351.517.83%8.82%7.20%5/7/2024 (Confirmed)
ICU Medical, Inc. stock logo
ICUI
ICU Medical
-$29.66M-$1.23N/A17.57N/A-1.31%6.35%3.03%5/7/2024 (Confirmed)
NuVasive, Inc. stock logo
NUVA
NuVasive
$40.41M$0.5079.5015.35N/A2.32%12.17%4.88%N/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$222.61M-$3.44N/AN/AN/A-29.77%-31.48%-10.75%5/2/2024 (Confirmed)

Latest CMD, TNDM, NUVA, ICUI, and GMED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.55N/A-$0.55N/AN/AN/A  
5/7/2024N/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.8350N/A-$0.8350N/AN/AN/A  
5/2/2024N/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.80N/A+$0.80N/AN/AN/A  
2/27/2024Q4 2023
ICU Medical, Inc. stock logo
ICUI
ICU Medical
$0.85$1.24+$0.39$3.19$564.77 million$587.86 million
2/21/2024Q4 2023
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.23-$0.27-$0.04-$0.08$204.86 million$196.80 million
2/20/2024Q4 2023
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.59$0.60+$0.01$1.09$608.21 million$616.53 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$0.210.26%N/A12.73%N/A
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
ICU Medical, Inc. stock logo
ICUI
ICU Medical
N/AN/AN/AN/AN/A
NuVasive, Inc. stock logo
NUVA
NuVasive
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cantel Medical Corp. stock logo
CMD
Cantel Medical
1.16
2.72
2.00
Globus Medical, Inc. stock logo
GMED
Globus Medical
0.10
4.88
2.72
ICU Medical, Inc. stock logo
ICUI
ICU Medical
0.74
2.53
1.06
NuVasive, Inc. stock logo
NUVA
NuVasive
0.50
1.25
0.65
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
0.91
3.83
3.02

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cantel Medical Corp. stock logo
CMD
Cantel Medical
84.13%
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
96.10%
NuVasive, Inc. stock logo
NUVA
NuVasive
N/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Cantel Medical Corp. stock logo
CMD
Cantel Medical
10.70%
Globus Medical, Inc. stock logo
GMED
Globus Medical
24.30%
ICU Medical, Inc. stock logo
ICUI
ICU Medical
6.70%
NuVasive, Inc. stock logo
NUVA
NuVasive
0.53%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cantel Medical Corp. stock logo
CMD
Cantel Medical
3,66944.51 millionN/AOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
5,000135.37 million102.48 millionOptionable
ICU Medical, Inc. stock logo
ICUI
ICU Medical
14,00024.36 million22.73 millionOptionable
NuVasive, Inc. stock logo
NUVA
NuVasive
3,00052.45 million52.17 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,40064.56 million62.95 millionOptionable

CMD, TNDM, ICUI, NUVA, and GMED Headlines

SourceHeadline
Tandem Diabetes Care (NASDAQ:TNDM) Lifted to Outperform at Leerink PartnrsTandem Diabetes Care (NASDAQ:TNDM) Lifted to Outperform at Leerink Partnrs
marketbeat.com - April 26 at 7:24 AM
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Average Recommendation of "Hold" by AnalystsTandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Average Recommendation of "Hold" by Analysts
americanbankingnews.com - April 26 at 1:38 AM
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to DeclineEarnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
zacks.com - April 25 at 11:05 AM
Jennison Associates LLC Has $38.18 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Jennison Associates LLC Has $38.18 Million Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
marketbeat.com - April 25 at 7:19 AM
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded to "Outperform" by SVB LeerinkTandem Diabetes Care (NASDAQ:TNDM) Upgraded to "Outperform" by SVB Leerink
marketbeat.com - April 25 at 7:11 AM
Tandem Diabetes Care (TNDM) to Release Earnings on ThursdayTandem Diabetes Care (TNDM) to Release Earnings on Thursday
americanbankingnews.com - April 25 at 2:14 AM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $40.00 at Stifel NicolausTandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $40.00 at Stifel Nicolaus
americanbankingnews.com - April 24 at 4:02 AM
Tandem Diabetes Care IncTandem Diabetes Care Inc
morningstar.com - April 23 at 10:56 PM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $40.00 by Analysts at Stifel NicolausTandem Diabetes Care (NASDAQ:TNDM) Price Target Increased to $40.00 by Analysts at Stifel Nicolaus
marketbeat.com - April 23 at 1:49 PM
Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 7.9%Tandem Diabetes Care (NASDAQ:TNDM) Shares Up 7.9%
marketbeat.com - April 23 at 1:25 PM
Contrasting Tandem Diabetes Care (NASDAQ:TNDM) & IceCure Medical (NASDAQ:ICCM)Contrasting Tandem Diabetes Care (NASDAQ:TNDM) & IceCure Medical (NASDAQ:ICCM)
americanbankingnews.com - April 20 at 2:04 AM
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at StockNews.comTandem Diabetes Care (NASDAQ:TNDM) Upgraded at StockNews.com
americanbankingnews.com - April 19 at 2:14 AM
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Mirae Asset Global Investments Co. Ltd.Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Sold by Mirae Asset Global Investments Co. Ltd.
marketbeat.com - April 17 at 4:44 AM
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 2.9%
marketbeat.com - April 15 at 1:55 PM
Raymond James & Associates Purchases 51,721 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)Raymond James & Associates Purchases 51,721 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
marketbeat.com - April 15 at 4:26 AM
Validea Detailed Fundamental Analysis - TNDMValidea Detailed Fundamental Analysis - TNDM
nasdaq.com - April 14 at 11:34 AM
Tandem Diabetes Care (NASDAQ:TNDM) Downgraded by StockNews.com to SellTandem Diabetes Care (NASDAQ:TNDM) Downgraded by StockNews.com to Sell
marketbeat.com - April 11 at 11:12 PM
Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024Tandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024
businesswire.com - April 9 at 4:05 PM
Whats Driving Tandem Diabetes Care Incs Surprising 25% Stock Rally?What's Driving Tandem Diabetes Care Inc's Surprising 25% Stock Rally?
gurufocus.com - April 9 at 12:02 PM
Bullish Tandem Diabetes Care Insiders Loaded Up On US$725.5k Of StockBullish Tandem Diabetes Care Insiders Loaded Up On US$725.5k Of Stock
finance.yahoo.com - April 9 at 8:55 AM
1 Beaten-Down Stock That Could Make You Richer1 Beaten-Down Stock That Could Make You Richer
fool.com - April 7 at 12:07 PM
Should You Invest in Tandem Diabetes Care (TNDM)?Should You Invest in Tandem Diabetes Care (TNDM)?
finance.yahoo.com - April 5 at 9:49 AM
Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $38.00Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $38.00
marketbeat.com - April 3 at 3:22 PM
Tandem Mobi automated insulin pump wins FDA nod for expanded pediatric useTandem Mobi automated insulin pump wins FDA nod for expanded pediatric use
drugdeliverybusiness.com - April 2 at 2:43 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cantel Medical logo

Cantel Medical

NYSE:CMD
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.
Globus Medical logo

Globus Medical

NYSE:GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
ICU Medical logo

ICU Medical

NASDAQ:ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
NuVasive logo

NuVasive

NASDAQ:NUVA
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.
Tandem Diabetes Care logo

Tandem Diabetes Care

NASDAQ:TNDM
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.